Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 7/30/2014 11:04:59 PM - Followers: 1092 - Board type: Free - Posts Today: 0
PostSubject
#180855  Sticky Note INCY, Roche ink non-exclusive clinical collaboration to test DewDiligence 07/30/14 03:13:31 PM
#180827  Sticky Note REGN PCSK9 mAb data from 9 Ph3 trials reported. biotech jim 07/30/14 08:17:45 AM
#180794  Sticky Note SRPT BoD limits CEO’s participation in FDA meetings: DewDiligence 07/29/14 04:21:04 PM
#180783  Sticky Note Targacept historical perspective. rkrw 07/29/14 12:54:17 PM
#180759  Sticky Note Cheat Sheet for GILD’s Phase-3 Trials of Sovaldi+GS-5816* DewDiligence 07/28/14 02:20:15 PM
#180080  Sticky Note What is your view on RGDO?From day one, DewDiligence 07/03/14 11:44:16 AM
#180868   Perhaps iwfal's skepticism is well founded and only iwfal 07/30/14 11:04:59 PM
#180867   ?? Merck & Co. UBS ariadndndough 07/30/14 10:41:37 PM
#180866   GILD insiders feel the heat of competition that jbog 07/30/14 08:58:43 PM
#180865   I was surprised at the price tag also. biotech jim 07/30/14 08:37:10 PM
#180864   BMRN: for an ultra rare disease, BMRN can take ghmm 07/30/14 07:19:59 PM
#180863   for an ultra rare disease, BMRN can take masterlongevity 07/30/14 07:03:58 PM
#180862   Your not just talking to yourself :-). ghmm 07/30/14 06:46:36 PM
#180861   Rbc notes regn ariadndndough 07/30/14 06:08:06 PM
#180860   The one area of rare disease therapy worth masterlongevity 07/30/14 05:30:05 PM
#180859   Ya, he only gets to take home $2.6m Dew... gdollasign 07/30/14 05:08:25 PM
#180858   Regeneron and Sanofi Announce Plan to Use Priority biotech jim 07/30/14 05:06:41 PM
#180857   That's chump change to him. jbog 07/30/14 04:50:07 PM
#180856   Perhaps iwfal's skepticism is well founded and only iwfal 07/30/14 04:37:13 PM
#180855   INCY, Roche ink non-exclusive clinical collaboration to test DewDiligence 07/30/14 03:13:31 PM
#180854   Yes they do but it's all political theatre masterlongevity 07/30/14 03:06:49 PM
#180853   Just my opinion but since many of the ghmm 07/30/14 03:01:36 PM
#180852   $4M sale by GILD director just filed: DewDiligence 07/30/14 02:57:26 PM
#180851   Appreciate your and iwfal's points of Adaptive Trials. ghmm 07/30/14 02:56:03 PM
#180850   Master my poster boy candidate would be Hetlioz rogerm 07/30/14 02:48:01 PM
#180849   The FDA side is up now ghmm 07/30/14 02:47:06 PM
#180848   It just amazes me, we went to swampboots 07/30/14 02:22:29 PM
#180847   again, i would say not enough people are masterlongevity 07/30/14 01:24:36 PM
#180846   well, there are also 2 different ways to masterlongevity 07/30/14 01:22:21 PM
#180845   adaptive, and not necessarily bayesian, can also be iwfal 07/30/14 01:09:48 PM
#180844   BioPharm Executive: Have Drugs Finally Been Priced Too masterlongevity 07/30/14 01:09:33 PM
#180843   adaptive, and not necessarily bayesian, can also be masterlongevity 07/30/14 12:52:54 PM
#180842   adaptive trial designs are a great idea and masterlongevity 07/30/14 12:46:41 PM
#180841   AZN acquires respiratory portfolio and pipeline from Almirall: DewDiligence 07/30/14 12:32:17 PM
#180840   Hopefully this should shut her up for good kris_kade 07/30/14 11:58:07 AM
#180839   I didn't say DMD was easier. You started masterlongevity 07/30/14 11:51:12 AM
#180838   Emil Kakkis has been a big advocate for iwfal 07/30/14 11:45:53 AM
#180837   That's my point. If inclusion criteria were so masterlongevity 07/30/14 11:42:08 AM
#180836   Thanks 'frontiers' for posting that, as I had biotech jim 07/30/14 11:26:53 AM
#180834   Webcast Calendar ghmm 07/30/14 11:04:49 AM
#180833   Well written article on the Fed's comments on frontiers 07/30/14 10:47:30 AM
#180832   GALT> GR-MD-02 is administered by IV. Even if biocqr 07/30/14 10:36:07 AM
#180831   GALT: Yes, noted. swampboots 07/30/14 10:08:30 AM
#180830   GALT has been a shady company for a vinmantoo 07/30/14 10:05:49 AM
#180829   Researchers Fret as Social Media Lift Veil on ghmm 07/30/14 09:47:38 AM
#180828   Galt: sometimes data results to me are similar swampboots 07/30/14 09:36:17 AM
#180827   REGN PCSK9 mAb data from 9 Ph3 trials reported. biotech jim 07/30/14 08:17:45 AM
#180826   This can't be good. Should they be Double_Bagel 07/30/14 07:50:49 AM
#180825   >> By focusing on RNA and PTCT I jq1234 07/30/14 02:41:25 AM
#180824   SRPT If you really think not much has iwfal 07/30/14 02:04:43 AM
#180823   >> Companies like STPT popping up all over jq1234 07/30/14 01:49:07 AM
#180822   Which AR-509 trial is biggest threat to Xtandi BayAreaBiotechI 07/30/14 01:19:32 AM
#180821   That explains why the rate of success in masterlongevity 07/30/14 12:58:18 AM
#180820   What chemo has been approved for Nonmetastatic CRPC jq1234 07/30/14 12:48:21 AM
#180819   MDVN: Why is control arm placebo and not BayAreaBiotechI 07/30/14 12:36:04 AM
#180818   >> How much have they really learned in jq1234 07/30/14 12:08:01 AM
PostSubject